NCT07930585: Transmission-Blocking Vaccine Pvs230D1-EPA/Matrix-M in Healthy Malaria-Naive Adults Using a Plasmodium Vivax Controlled Human Malaria Infection and Transmission Model
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 220 planned
- Started
- 23 Nov 2026
- Primary completion
- 1 Nov 2029
- Arms
- Booster Vaccine, Primary Vaccine Series
- Results
- None posted
- 12 Nov 2026: Trial registered